Product image of Fibrogammin (Human Coagulation Factor Xiii) supplied by GNH India

Fibrogammin

Active Ingredient:
Human Coagulation Factor Xiii
Origin:
EU

Fibrogammin (Human Coagulation Factor Xiii)

Fibrogammin is a human coagulation factor XIII used to manage bleeding disorders. This intravenous medication supports blood clotting and is sourced from CSL Behring GmbH in the EU.

Manufacturer / TM Owner

Csl Behring Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Fibrogammin is primarily used to treat bleeding disorders caused by a deficiency in coagulation factor XIII. This medication helps the blood to clot properly, which is essential for managing conditions where excessive bleeding occurs. It is often administered to patients who have undergone surgery or are at risk of bleeding due to congenital or acquired factor XIII deficiency.

Side Effects

  • Common effects of Fibrogammin may include mild reactions at the injection site, such as redness or swelling. Some individuals might experience allergic reactions, which can range from mild to severe. It is important to monitor for any signs of an adverse reaction and consult a healthcare provider if necessary.

Precautions & Warnings

  • Fibrogammin should be handled with care, ensuring it is stored and administered according to medical guidelines. Patients with a history of allergic reactions to blood products should use this medication with caution. Always follow the advice of a healthcare professional regarding the use of Fibrogammin.

Avoid Interactions

  • Fibrogammin may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements might also affect the efficacy of Fibrogammin.

Frequently Asked Questions

Fibrogammin is used to treat bleeding disorders caused by a deficiency in coagulation factor XIII, helping the blood to clot properly.

Fibrogammin is administered intravenously, typically under the supervision of a healthcare provider.

Common side effects may include mild reactions at the injection site, such as redness or swelling, and allergic reactions.

Patients with a history of allergic reactions to blood products should use Fibrogammin with caution.

It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions with Fibrogammin.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Xiii

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT